Table 2.
Odds ratio | 95% Confidence interval | p-value | |
---|---|---|---|
Age ≤ 65 at metastatic diagnosis | 3.63 | 1.43-9.17 | 0.005 |
Metastasis-free interval > 40 mo | 2.61 | 1.08-6.31 | 0.03 |
Orange pigment over melanoma | 4.20 | 1.48-11.9 | 0.005 |
Smaller largest diameter of the largest liver metastasis | 0.97 | 0.94-0.99 | 0.034 |
Metastasis diagnosis by surveillance testing | 2.90 | 1.04-8.04 | 0.037 |
Lower ECOG performance status | 0.34 | 0.15-0.74 | 0.007 |
Asymptomatic patient | 3.61 | 1.36-9.55 | 0.008 |
Unaltered lactate dehydrogenase | 4.63 | 1.77-12.05 | 0.001 |
Unaltered aspartate transaminase | 9.17 | 2.46-34.48 | < 0.001 |
Unaltered alanine transaminase | 6.90 | 1.85-25.64 | 0.002 |
Unaltered alkaline phosphatase | 20.41 | 2.55-166.67 | < 0.001 |
Unaltered gamma glutamyl transpeptidase | 9.17 | 3.02-27.78 | < 0.001 |
Surgery of first metastasis | 8.67 | 2.56-29.41 | < 0.001 |
ECOG, Eastern Cooperative Oncology Group.